| mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant VV Edara, KE Manning, M Ellis, L Lai, KM Moore, SL Foster, K Floyd, ... Cell Reports Medicine 3 (2), 2022 | 200 | 2022 |
| Neutralization against BA. 2.75. 2, BQ. 1.1, and XBB from mRNA Bivalent Booster ME Davis-Gardner, L Lai, B Wali, H Samaha, D Solis, M Lee, ... New England Journal of Medicine 388 (2), 183-185, 2023 | 178 | 2023 |
| Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study A Ozonoff, J Schaenman, ND Jayavelu, CE Milliren, CS Calfee, CB Cairns, ... EBioMedicine 83, 2022 | 38 | 2022 |
| SARS-CoV-2 variant vaccine boosters trial: preliminary analyses AR Branche, NG Rouphael, DJ Diemert, AR Falsey, C Losada, LR Baden, ... MedRxiv, 2022.07. 12.22277336, 2022 | 36 | 2022 |
| Durability of immune responses to mRNA booster vaccination against COVID-19 PS Arunachalam, L Lai, H Samaha, Y Feng, M Hu, HS Hui, B Wali, M Ellis, ... The Journal of clinical investigation 133 (10), 2023 | 32 | 2023 |
| mRNA bivalent booster enhances neutralization against BA. 2.75. 2 and BQ. 1.1 ME Davis-Gardner, L Lai, B Wali, H Samaha, D Solis, M Lee, ... Biorxiv, 2022.10. 31.514636, 2022 | 28 | 2022 |
| Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients J Diray-Arce, S Fourati, ND Jayavelu, R Patel, C Maguire, AC Chang, ... Cell Reports Medicine 4 (6), 2023 | 16 | 2023 |
| Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial AR Branche, NG Rouphael, DJ Diemert, AR Falsey, C Losada, LR Baden, ... Nature medicine 29 (9), 2334-2346, 2023 | 15 | 2023 |
| Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose WA Werbel, AH Karaba, TPY Chiang, AB Massie, DM Brown, N Watson, ... American Journal of Transplantation 23 (6), 744-758, 2023 | 10 | 2023 |
| Heterologous versus homologous boosting elicits qualitatively distinct, BA. 5–cross-reactive T cells in transplant recipients EA Thompson, W Ngecu, L Stoddart, TS Johnston, A Chang, K Cascino, ... JCI insight 8 (10), 2023 | 7 | 2023 |
| Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study A Ozonoff, ND Jayavelu, S Liu, E Melamed, CE Milliren, J Qi, LN Geng, ... Nature communications 15 (1), 216, 2024 | 6 | 2024 |
| Bivalent and monovalent SARS-CoV-2 variant vaccine boosters improve coverage of the known antigenic landscape: results of the COVID-19 variant immunologic landscape (COVAIL) trial A Branche, N Rouphael, D Diemert, A Falsey, C Losada, LR Baden, ... Research Square, 2023 | 4 | 2023 |
| Right posterior insular epidural stimulation in rats with neuropathic pain induces a frequency-dependent and opioid system-mediated reduction of pain and its comorbid anxiety … Z Mehsein, S Kobaïter-Maarrawi, H Samaha, M El Shami, S Albeaini, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 128, 110845, 2024 | 2 | 2024 |
| AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans L Grigoryan, Y Feng, L Bellusci, L Lai, B Wali, M Ellis, M Yuan, ... Science Immunology 9 (94), eadi8039, 2024 | 1 | 2024 |
| Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV C Losada, H Samaha, EM Scherer, B Kazzi, L Khalil, I Ofotokun, ... Vaccines 11 (6), 1067, 2023 | 1 | 2023 |
| Calcification of the ascending aorta, left heart valves and coronaries: associated diseases and a new classification H Samaha, N Chalhoub, M Tabet, T Smayra, G Sleilaty Future Cardiology 18 (9), 687-695, 2022 | 1 | 2022 |
| Perioperative chemotherapy with modified FOLFIRINOX for nonmetastatic pancreatic cancer: a new standard of care? I Radi, R Samaha, J El Hajj, H Samaha, HR Kourie Future Oncology 17 (03), 229-233, 2021 | 1 | 2021 |
| Role of IgG glycans in severe COVID-19 inflammatory cytokine responses EM Scherer, JD Sherman, V Karmali, B Kumar, TW Simon, S Bechnak, ... The Journal of Immunology 210 (1_Supplement), 233.14-233.14, 2023 | | 2023 |
| Maintenance avelumab in metastatic bladder cancer as a step towards sequencing immunotherapy H Samaha, R Samaha, J Sarkis, J Kattan Immunotherapy 13 (4), 271-275, 2021 | | 2021 |
